SEC Filing Summary: AntriaBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AntriaBio, Inc. (not Rezolute, Inc.) on April 4, 2014, covering events occurring on March 31, 2014. The registrant is a Delaware corporation headquartered in Menlo Park, California.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a material definitive agreement involving equity compensation.
Material Changes and Agreements
On March 31, 2014, the Company entered into a Services Agreement with JSDC, Inc. for advisory services related to investor relations, digital strategy, and market awareness. Key terms include:
- Services: Evaluation of digital IR strategy, website analysis, and introductions to financial media, analysts, and fund managers.
- Compensation: An equity fee of 3,000,000 shares of common stock.
- Payment Schedule: Shares are payable in increments of 250,000 over twelve months, with the first 250,000 shares issued upon execution.
- Regulatory Status: The issuance is exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary risk disclosed relates to the dilution of existing shareholders due to the issuance of 3,000,000 shares of common stock. The securities issued are restricted and may not be sold in the United States absent registration or an applicable exemption.
Investor Verification Checklist
- Verify the total authorized share capital and the percentage of ownership represented by the 3,000,000 shares issued to JSDC, Inc.
- Confirm the current market price of AntriaBio, Inc. common stock to assess the fair value of the equity compensation.
- Review the full text of the Services Agreement (Exhibit 10.1) for specific performance milestones tied to the incremental share issuance.
- Check subsequent filings for any changes in the Company's capitalization table or additional equity issuances.